Our top pick for
Lemonade Inc is an insurance-property & casualty business based in the US. Lemonade shares (LMND) are listed on the NYSE and all prices are listed in US Dollars. Lemonade employs 567 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$63.47|
|52-week range||$46.60 - $188.30|
|50-day moving average||$68.68|
|200-day moving average||$83.19|
|Wall St. target price||$77.71|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.92|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-18)||-5.17%|
|1 month (2021-09-24)||-8.96%|
|3 months (2021-07-23)||-26.05%|
|6 months (2021-04-23)||-32.42%|
|1 year (2020-10-23)||24.23%|
|2 years (2019-10-21)||N/A|
|3 years (2018-10-21)||N/A|
|5 years (2016-10-21)||N/A|
|Revenue TTM||$90 million|
|Gross profit TTM||$39.7 million|
|Return on assets TTM||-10.92%|
|Return on equity TTM||-24.91%|
|Market capitalisation||$3.9 billion|
TTM: trailing 12 months
There are currently 12.0 million Lemonade shares held short by investors – that's known as Lemonade's "short interest". This figure is 11.3% up from 10.8 million last month.
There are a few different ways that this level of interest in shorting Lemonade shares can be evaluated.
Lemonade's "short interest ratio" (SIR) is the quantity of Lemonade shares currently shorted divided by the average quantity of Lemonade shares traded daily (recently around 1.1 million). Lemonade's SIR currently stands at 10.49. In other words for every 100,000 Lemonade shares traded daily on the market, roughly 10490 shares are currently held short.
However Lemonade's short interest can also be evaluated against the total number of Lemonade shares, or, against the total number of tradable Lemonade shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lemonade's short interest could be expressed as 0.2% of the outstanding shares (for every 100,000 Lemonade shares in existence, roughly 200 shares are currently held short) or 0.3144% of the tradable shares (for every 100,000 tradable Lemonade shares, roughly 314 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Lemonade.
Find out more about how you can short Lemonade stock.
We're not expecting Lemonade to pay a dividend over the next 12 months.
Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products cover stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Find out how to stake your TRX tokens and how Tron’s delegated proof-of-stake consensus mechanism works.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.